This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

OPKO Health Announces The Appointment Of Greg Stanley As Vice President Of Sales And Marketing For Its Global Diagnostics Business Unit

OPKO Health, Inc. (NYSE:OPK) is pleased to announce the appointment of Greg Stanley as Vice President of Sales and Marketing for its global diagnostics business unit.

Mr. Stanley brings to OPKO extensive experience and expertise in the market development and commercial operations of diagnostic products and services. Prior to joining OPKO, Mr. Stanley served as chief commercial officer of Oncimmune USA, LLC where he led the commercial strategy and market development for the company’s oncology platform in early cancer detection. Most notable was the successful launch and market growth of EarlyCDT®-Lung, the first commercially available blood test to aid in the early detection of lung cancer. Prior to this, Mr. Stanley served over 5 years as director of marketing and then national director of corporate accounts, for Roche Diagnostics where he led the successful market introduction of numerous diagnostic products in point of care, immunodiagnostics, hematology, clinical chemistry, blood gas, urinalysis and blood glucose. Mr. Stanley had increasing scope of responsibility in sales, marketing and management roles at Abbott Diagnostics, Chiron Corporation, and Radiometer prior to his time at Roche. He has been at the executive leadership level for over 15 years and during his tenure served on the board of directors for Radiometer and Oncimmune. Mr. Stanley received his B.S. degree, Business Administration, from the University of Missouri-St. Louis.

“We are excited to have Greg joining the OPKO Diagnostics team here in Miami,” said David Okrongly, President of OPKO Diagnostics. “His experience at launching and gaining reimbursement for novel cancer diagnostic tests combined with his broad background in IVD sales and marketing is the perfect combination for the commercial leadership role in the OPKO Diagnostics business unit.”

“We are fortunate to have Greg join the OPKO Diagnostics team where his commercial expertise will have a significant impact as we prepare for the launch of the 4Kscore™ prostate cancer diagnostic test and the Claros®1 in-office immunodiagnostic analyzer,” said Phillip Frost, M.D., OPKO's Chairman and Chief Executive Officer.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,083.80 -2.83 -0.02%
S&P 500 1,987.98 +0.97 0.05%
NASDAQ 4,472.1080 -1.5890 -0.04%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs